Strides to acquire remaining stake in Vivimed

Pharma |  News | 0 Comment | 30 Jan, 2019

Strides Pharma Science Limited has announced that the Board of Directors of Strides and its step down subsidiary Strides Pharma Global Pte Limited, Singapore have approved to convert their ...Read more

LEO Pharma appoints Thomas Hultsch as Head of Translational Medicine

Pharma |  News | 0 Comment | 29 Jan, 2019

LEO Pharma specialized in medical dermatology has announced that Thomas Hultsch has been appointed as Head of Translational Medicine as of 28 January, 2019. Thomas Hultsch's primary task w...Read more

I-Mab gets USFDA IND approval for its proprietary TJC4

Pharma |  News | 0 Comment | 29 Jan, 2019

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

Merck enters into an exclusive licensing agreement with Vertex

Pharma |  News | 0 Comment | 25 Jan, 2019

Merck, a leading science and technology company has announced that it has entered into an exclusive licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA for two DNA-dep...Read more

Meiji Seika, Toray sign license agreement for antipuritic agent

Pharma |  News | 0 Comment | 25 Jan, 2019

Toray Industries, Inc. and Meiji Seika Pharma Co., Ltd. have announced that the companies have signed an exclusive license agreement on the orally disintegrating tablets formulation of anti...Read more

Vifor Pharma updates PIVOTAL trial results

Pharma |  News | 0 Comment | 24 Jan, 2019

No difference in the infection rate Further to the announcement on 29 October 2018, Vifor Pharma provides an update to the results of the Proactive IV irOn Therapy in haemodiALysis patients...Read more

ASLAN annouces publication of new pre-clinical data

Pharma |  News | 0 Comment | 24 Jan, 2019

ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, has announ...Read more

Cannabics to sponsor and showcase its technology at WEF 2019

Pharma |  News | 0 Comment | 23 Jan, 2019

Cannabics Pharmaceuticals Inc., a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that Mr. Eyal Barad, Co-Founder and CEO, and Dr. Ey...Read more

Immunochina raises $20.4 M to expand manufacturing facility

Pharma |  News | 0 Comment | 23 Jan, 2019

Beijing-based Immunochina Pharmaceuticals recently announced the closing of its $20.4 million Series C financing. This financing will enable the company to expand its GMP-grade manufacturi...Read more

Mundipharma to bring cold-fighting product to Africa, ME

Pharma |  News | 0 Comment | 22 Jan, 2019

Mundipharma will be introducing BETADINE Cold Defence, a new early treatment hailed as a “world-first”, in the Middle East (ME) and Africa to help families stay healthy and figh...Read more

Zydus gets tentative USFDA approval for acid reflux capsules

Pharma |  News | 0 Comment | 22 Jan, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The company has received the tentative...Read more

Eisai listed as Global 100 most sustainable corporation

Pharma |  News | 0 Comment | 22 Jan, 2019

Eisai Co., Ltd. has been listed in the 2019 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corpo...Read more

OPTIMA, METALL+PLASTIC to show new technology at Pharma Congress

Pharma |  News | 1 Comment | 22 Jan, 2019

Pharma Congress Production & Technology will be held in Düsseldorf from April 9 to 10, 2019, and experts from Optima Pharma and Metall+Plastic will be returning once again. This ti...Read more

US FDA approves Samsung Bioepis' first oncology drug

Pharma |  News | 0 Comment | 21 Jan, 2019

Samsung Bioepis has announced that the U.S. Food and Drug Administration has approved ONTRUZANT, a biosimilar referencing HERCEPTIN (trastuzumab), across all eligible indications, name...Read more

Invitrocue inks deal with German firm Systasy Bioscience GmbH

Pharma |  News | 0 Comment | 18 Jan, 2019

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the signing of its first laboratory agreement in Germany as part of its strategy to make its Onco-PD...Read more

Sandoz launches SYMJEPI™ (epinephrine) in US

Pharma |  News | 0 Comment | 18 Jan, 2019

Adamis Pharmaceuticals Corporation has announced that its marketing and commercial partner, Sandoz Inc. (Sandoz), a Novartis division, has launched SYMJEPI™ (epine...Read more

Luye Pharma strengthens commitment to cardiovascular therapeutic field

Pharma |  News | 0 Comment | 17 Jan, 2019

Luye Pharma has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma's Xuezhikang Capsules in mainland China. Thi...Read more

CANbridge Pharmaceuticals, GC Pharma announce Greater China licensing agreement for Hunter Syndrome

Pharma |  News | 0 Comment | 16 Jan, 2019

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, and GC Pharma (formerly...Read more